Electroencephalographic Biofeedback in the Treatment of Attention-Deficit/ Hyperactivity Disorder

Yazarlar

  • Vincent J. Monastra
  • Steven Lynn
  • Michael Linden
  • Joel F. Lubar
  • John Gruzelier
  • Theodore J. La Vaque

DOI:

https://doi.org/10.1300/J184v09n04_02

Özet

Historically, pharmacological treatments for attention deficit/
hyperactivity disorder (ADHD) have been considered to be the
only type of interventions effective for reducing the core symptoms of this condition. However, during the past three decades, a series of caseand controlled-group studies examining the effects of EEG biofeedback have reported improved attention and behavioral control, increased cortical activation on quantitative electroencephalographic examination, and gains on tests of intelligence and academic achievement in response to this type of treatment. This review paper critically examines the empirical evidence, applying the efficacy guidelines jointly established by the Association for Applied Psychophysiology and Biofeedback (AAPB) and the International Society for Neuronal Regulation (ISNR). On the basis of these scientific principles, EEG biofeedback was determined to be “probably efficacious” for the treatment of ADHD. Although significant clinical improvement was reported in approximately 75% of the patients in each of the published research studies, additional randomized, controlled group studies are needed in order to provide a better estimate of the percentage of patients with ADHD who will demonstrate such gains in clinical practice.

İndir

Yayınlanmış

2016-10-13

Sayı

Cilt 9 Sayı 4 (2005)

Bölüm

SCIENTIFIC FEATURES

Lisans

© International Society for Neurofeedback and Research (ISNR), all rights reserved. This article (the “Article”) may be accessed online from ISNR at no charge. The Article may be viewed online, stored in electronic or physical form, or archived for research, teaching, and private study purposes. The Article may be archived in public libraries or university libraries at the direction of said public library or university library. Any other reproduction of the Article for redistribution, sale, resale, loan, sublicensing, systematic supply, or other distribution, including both physical and electronic reproduction for such purposes, is expressly forbidden. Preparing or reproducing derivative works of this article is expressly forbidden. ISNR makes no representation or warranty as to the accuracy or completeness of any content in the Article.  From 1995 to 2013 the Journal of Neurotherapy was the official publication of ISNR (www. Isnr.org); on April 27, 2016 ISNR acquired the journal from Taylor & Francis Group, LLC. In 2014, ISNR established its official open-access journal NeuroRegulation (ISSN: 2373-0587; www.neuroregulation.org).